Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity
- PMID: 17645726
- DOI: 10.1111/j.1749-0774.2007.00030.x
Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity
Abstract
A new cell line (NOE) of human ovarian endometrioid carcinoma was established and characterized. The cell line showed a short spindle-shaped morphology and continued to grow for more than 4 months without contact inhibition. The doubling time was approximately 15.5 h at the 10th passage. The chromosome number was aneuploid. The IC50 values of paclitaxel, cisplatin and carboplatin were 26.4 ng/mL, 2.4 microg/mL and 32.5 microg/mL, respectively. The NOE cells expressed estrogen receptor alpha. In nude mice, we confirmed tumor formation of NOE cells. These results indicated that NOE cells showed similar chemosensitivity and properties to those of the original tumor and might be useful in basic studies on the diagnosis, treatment and etiology of ovarian tumors.
Similar articles
-
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.Hum Cell. 2017 Jul;30(3):226-236. doi: 10.1007/s13577-017-0162-1. Epub 2017 Mar 1. Hum Cell. 2017. PMID: 28251557
-
Establishment and characterization of a cell line derived from a human serous surface papillary carcinoma of the ovary.Hum Cell. 2006 Nov;19(4):133-7. doi: 10.1111/j.1749-0774.2006.00021.x. Hum Cell. 2006. PMID: 17257376
-
Sensitivity to taxoid derivatives of a newly established human endometrioid ovarian adenocarcinoma radioresistant cell line.Anticancer Res. 1996 Jan-Feb;16(1):177-87. Anticancer Res. 1996. PMID: 8615606
-
Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.Hum Cell. 2016 Oct;29(4):181-7. doi: 10.1007/s13577-016-0138-6. Epub 2016 Mar 9. Hum Cell. 2016. PMID: 26960408
-
MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG.Cancer Lett. 2014 Oct 28;353(2):201-10. doi: 10.1016/j.canlet.2014.07.026. Epub 2014 Jul 22. Cancer Lett. 2014. PMID: 25063739
Cited by
-
Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells.Oncotarget. 2018 Aug 24;9(66):32609-32623. doi: 10.18632/oncotarget.25975. eCollection 2018 Aug 24. Oncotarget. 2018. PMID: 30220969 Free PMC article.
-
Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer.Int J Mol Sci. 2024 Jan 28;25(3):1626. doi: 10.3390/ijms25031626. Int J Mol Sci. 2024. PMID: 38338902 Free PMC article.
-
The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells.Cancer Sci. 2010 Feb;101(2):347-54. doi: 10.1111/j.1349-7006.2009.01378.x. Epub 2009 Oct 3. Cancer Sci. 2010. PMID: 19917055 Free PMC article.
-
HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells.Oncotarget. 2015 May 30;6(15):13359-70. doi: 10.18632/oncotarget.3673. Oncotarget. 2015. PMID: 25944620 Free PMC article.
-
Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary.J Ovarian Res. 2013 Feb 4;6(1):8. doi: 10.1186/1757-2215-6-8. J Ovarian Res. 2013. PMID: 23379414 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials